The Dermatology Digest

MAY 14, 2024

The American Skin Association’s (ASA) SPOTS (Sun Protection Outreach Teaching by Students) program will receive the inaugural 2024 Research Achievement Award in Community Education/Outreach at the upcoming 2024 Society for Investigative Dermatology (SID) Annual Meeting in Dallas, TX. We are honored to receive this award.”

Sun Protection 36

Sun Protection Partnerships Education Safety 36

The Dermatology Digest

JANUARY 30, 2024

The Pediatric Dermatology Research Alliance (PeDRA) has awarded nearly $240K to support pediatric dermatology research across four competitive grant programs. Run in partnership with NAAF, the Pediatric Alopecia Areata Challenge Grant supports research investigations focused on pediatric alopecia areata.

Partnerships 36

Partnerships Eczema Hospital Dermatology 36

The Dermatology Digest

DECEMBER 20, 2023

Mr. Raducha-Grace recently served as Head of Clinical Partnerships at Harbor Health. Secondary measures of efficacy, as well as safety and pharmacokinetics, will also be assessed. Head of the SAB, Is a Professor of Dermatology with Penn State Health Hershey Medical Center, and Penn State College of Medicine. Billingsley, MD.,

Dermatology 36

Dermatology Surgery Eczema Office 36

The Dermatology Digest

JULY 22, 2024

“This launch symbolizes the robustness of our platform, the value of our partnership with STADA, and our collective focus on the importance of biosimilars.” The post Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe appeared first on The Dermatology Digest.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

SEPTEMBER 9, 2024

In a preliminary review by an independent data safety committee, the ongoing study of 60 patients demonstrated a much lower incidence and severity of side effects as well as improved efficacy for preventing Raynaud’s attacks, when compared to published reviews of current therapies. and Abroad appeared first on The Dermatology Digest.

Portfolios 36

Portfolios Dermatology Injections Marketing 36

The Dermatology Digest

SEPTEMBER 30, 2024

In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. Otulfi demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity to Stelara in patients with moderate to severe psoriasis vulgaris.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

The Dermatology Digest

FEBRUARY 27, 2024

This approval marks an important milestone for Teva and Alvotech’s partnership to collaborate on seven biosimilars and expand the availability, access, and uptake of biosimilars in the U.S.” The post Biosimilar News: FDA Approves Simlandi as Third Interchangeable Humira Biosimilar appeared first on The Dermatology Digest.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

MARCH 20, 2024

Starting at this year’s Miami Open, La Roche-Posay will have a Sun Safety Booth located on the Tennis Oasis, two additional sampling kiosks at key entry points, while also providing sunscreen to players and staff on the grounds. The Miami Open is taking place from March 17 to March 31 at Hard Rock Stadium in Miami Gardens, Florida.

Branding 36

Branding Partnerships Safety Dermatology 36

The Dermatology Digest

JANUARY 4, 2024

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. The post Biosimilar Watch: FDA Accepts BLA for Proposed Stelara Biosimilar appeared first on The Dermatology Digest. commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

The Dermatology Digest

JULY 23, 2024

The approval for treatment of upper facial lines stems from clinical studies demonstrating the simultaneous treatment efficacy and safety of XEOMIN. The new indication comes on the coattails of the brand’s partnership with Demi Lovato and the continuation of the Merz Aesthetics multi-channel, digital-first ‘Beauty on Your Terms’ campaign.

Facials 36

Facials Partnerships Ingredients Injections 36

The Dermatology Digest

DECEMBER 18, 2023

The Joint Task Force is a partnership between the American College of Allergy, Asthma, and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology. The new AD guidelines also: • Highlight the safety of the topical calcineurin inhibitors with typical usage once or twice daily.

Dermatitis 36

Dermatitis Partnerships Therapy Diet 36

US Dermatologt Partners

FEBRUARY 7, 2024

Botox is one of the most popular cosmetic dermatology treatments. Dermatology Partners in Cedar Park, Texas , “ Botox treatment offers dramatic improvement in the appearance of facial lines and wrinkles without the need for advanced or invasive procedures. Dermatology Partners to schedule a consultation visit.

Injections 41

Injections Wrinkles Facials Treatments 41

First Derm

NOVEMBER 25, 2023

Relationship impact : honesty and safety measures are key. Given their prevalence, especially among men seeking dermatological care, healthcare providers have a crucial opportunity for timely intervention and treatment. Journal of Dermatology for Physician Assistants. Vaccination and safe sex prevent HPV and warts. Ho N, Leon S.

Safety 45

Safety Education Clinic Therapy 45

The Dermatology Digest

MARCH 27, 2025

have entered into a collaboration and licensing agreement to develop, manufacture, and commercialize ESK-001, a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor, for dermatology indications in Japan, with the option to expand the license to include rheumatological and gastrointestinal diseases. Alumis Inc.

Pharmaceutical 36

Pharmaceutical Portfolios Clinic Safety 36

The Dermatology Digest

NOVEMBER 12, 2024

And the winners are… The 2024 recipients of the American Society for Dermatologic Surgery’s (ASDS) annual awards were recognized during the Society’s Annual Membership Meeting during the ASDS Annual Meeting in Orlando, FL. He spoke about, “Innovations in Dermatologic Surgery: From the Microscope to the Bedside.” Lawrence M.

Surgery 36

Surgery Innovations Education Dermatology 36